Identifying effective therapies for adult-onset neurodegenerative diseases has been a major challenge. For example, although the gene that causes Huntington's disease (HD) has been identified, its protein product appears to lack receptor or enzymatic activity that could be disrupted with therapeutic
No takes yet. Share an insight, caveat, or question.
Finkbeiner et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: